TNF and inflammatory bowel disease: Furthermore, development of the secondary psoriatic lesions was observed not only in patients receiving anti-TNF agents due to IBD, but also in individuals who received drugs from this group due to the presence of other immune-mediated conditions, such as rheumatoid arthritis (RA), ankylosing spondylitis and juvenile arthritis [32, 90, 171].